Accelerating development of scientific evidence for medical products within the existing US regulatory framework
2017
Growing access to diverse 'real-world' data sources is enabling new approaches to close persistent evidence gaps about the optimal use of medical products in real-world practice. Here, we argue that contrary to widespread impressions, existing FDA regulations embody sufficient flexibility to accommodate the emerging tools and methods needed to achieve this goal.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
4
References
35
Citations
NaN
KQI